Abstract:beta-Defensins are a family of conserved small cationic antimicrobial peptides with different significant biological functions. The majority of mammalian beta-defensins are expressed in epididymis, and many of them are predicted to have post-translational modifications. However, only a few of its members have been well studied due to the limitations of expressing and purifying bioactive proteins with correct post-translational modifications efficiently. Here we developed a novel Fc tagged lentiviral system and Fc tagged prokaryotic expression systems provided new options for beta-defensins expression and purification. The novel lentiviral system contains a secretive signal peptide, an N-terminal IgG Fc tag, a green fluorescent protein (GFP), and a puromycin selection marker to facilitate efficient expression and fast purification of beta-defensins by protein A magnetic or agarose beads. It also enables stable and large-scale expression of beta-defensins with regular biological activities and post-translational modification. Purified beta-defensins such as Bin1b and a novel human beta-defensin hBD129 showed antimicrobial activity, immuno-regulatory activity, and expected post-translational phosphorylation, which were not found in Escherichia coli (E. coli) in expressed form. Furthermore, we successfully applied the novel system to identify mBin1b interacting proteins, explaining Bin1b in a better way. These results suggest that the novel lentiviral system is a powerful approach to produce correct post-translational processed beta-defensins with bioactivities and is useful to identify their interacting proteins. This study has laid the foundation for future studies to characterize function and mechanism of novel beta-defensins.

An Improved Lentiviral System for Efficient Expression and Purification of Β‐defensins in Mammalian Cells

Soluble fusion expression and characterization of bioactive human beta-defensin 26 and 27

Preferential codons enhancing the expression level of human beta-defensin-2 in recombinant Escherichia coli.

High-level Production of Bioactive Human Beta-Defensin-4 in Escherichia Coli by Soluble Fusion Expression

Soluble Fusion Expression and Characterization of Human Beta-Defensin 3 Using a Novel Approach.

Production and characterization of recombinant human beta-defensin DEFB120.

Cloning and Expression of Human Beta-Defensin-2 Gene in Escherichia Coli

Intein-mediated Expression is an Effective Approach in the Study of Β-Defensins

Recent advances in the research and development of human defensins.

High-level Expression of Soluble Human Β-Defensin-2 in Escherichia Coli

Fusion expression of human beta-defensin-2 from multiple joined genes in Escherichia coli.

[Construction and Expression of Recombinant Adenovirus Expression Vector of Beta-Defensin-2].

Expression of human beta-defensin-2 with multiple joined genes in Escherichia coli.

Expression and Functional Characterization of a Novel Antimicrobial Peptide: Human Beta-Defensin 118.

Enhanced Expression and Primary Purification of Soluble HBD3 Fusion Protein in Escherichia coli

Production Of Bioactive Human Beta-Defensin-3 In Escherichia Coli By Soluble Fusion Expression

Prokaryotic Expression and Purification of Mouse Epididymial Specific β-Defensin 48

Construction of Eukaryotic Expression Vector with Mbd1-Mbd3 Genes and Exploring Its Activity Against Influenza Virus in Vitro

Prokaryotic expression of antimicrobial ovine beta-defensin-1 in Escherichia coli

Expression and purification of rabbit defensin from E.coli with self-cleavable fusion protein

[Advances in the Research of Human Defensins].